Respiratory syncytial virus induces inflammation in bronchial asthma: Role of eosinophils

Allergology International

Volumn 53, Issue 4, 2004, Pages 301-307

  Kato, Masahiko ^a   Kimura, Hirokazu ^b  

^a Gunma Children's Medical Center   (Japan)

^b GUNMA PREFECTURAL INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

Author keywords

Adhesion; Asthma; Eosinophils; Respiratory syncytial virus

Indexed keywords

ALPHA 2 MACROGLOBULIN; BETA2 INTEGRIN; CHEMOKINE; CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PEROXIDASE; EOSINOPHIL TOXIC GRANULE PROTEIN; LIPID; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR BASIC PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL ADHESION; CELL DAMAGE; DEGRANULATION; DISEASE ASSOCIATION; DISEASE EXACERBATION; EFFECTOR CELL; EOSINOPHIL; EOSINOPHIL DEGRANULATION; EPITHELIUM CELL; INFLAMMATION; LEUKOCYTE COUNT; LUNG FUNCTION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYSTEM; REVIEW; RISK FACTOR; VIRUS INFECTION; WHEEZING;

EID: 11144302506     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1592.2004.00352.x     Document Type: Review

References (39)

1. Busse WW, Gern JE. Viruses in asthma. J. Allergy Clin. Immunol. 1997; 100: 147-50.
2. Stein RT, Sherrill D, Morgan WJ et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354: 541-5.
3. Heilman CA. Respiratory syncytial and parainfluenzo viruses. J. Infect. Dis. 1990; 161: 402-6.
4. Black CP. Systematic review of the biology and medical management of respiratory syncytial virus infection. Respir. Care 2003; 48: 209-33.
5. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993; 307: 982-6.
6. Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310: 1225-9.
7. Brauard J, Freymuth F, Toutain F et al. Role of viral infections and Chlamydia pneumoniae and Mycoplasma pneumoniae infections in asthma in infants and young children. Epidemiologic study of 118 children. Arch. Pediatr. Suppl. 2002; 3: S365-71.
8. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 2000; 161: 1501-7.
9. Kneyber MCJ, Steyerberg EW, de Groot R, Moll HA. Long-term effects of respiratory syncytial virus (RSV) bronchialitis in infants and young children: A quantitative review. Acta Paediatr. 2000; 89: 654-60.
10. Singleton RJ, Redding GJ, Lewis TC et al. Sequelae of severe respiratory syncytial virus infection in infancy and early childhood among Alaska Native children. Pediatrics 2003; 112: 285-90.
11. Kotaniemi-Syrjanen A, Reijonen TM, Korhonen K, Korppi M. Wheezing requiring hospitalization in early childhood: Predictive factors for asthma in a six-year follow-up. Pediatr. Allergy Immunol. 2002; 13: 418-25.
12. Everard ML, Swarbrick A, Wrightham M et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch. Dis. Child. 1994; 71: 428-32.
13. Noah TL, Becker S. Respiratory syncytial virus-induced cytokine production by human bronchial epithelial cell line. Am. J. Physiol. 1993; 265: L472-8.
14. Busse WW, Lemanske Jr RF. Advances in immunology: Asthma. N. Engl. J. Med. 2001; 344: 350-62.
15. Leiferman KM. A role for eosinophils in atopic dermatitis. J. Am. Acad. Dermatol. 2001; 45 (Suppl.): S21-4.
16. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J. Allergy Clin. Immunol. 2000; 105: 651-63.
17. Patel KD. Eosinophil tethering to interleukin-4-activated endothelial cells requires bath P-selectin and vascular cell adhesion molecule-1. Blood 1998; 92: 3904-11.
18. Garofalo R, Kimpen JL, Welliver RC, Ogra PL. Eosinophil degranulatian in the respiratory tract during naturally acquired respiratory syncytial virus infection. J. Pediatr. 1992; 120: 28-32.
19. Oymar K, Elsayed S, Bjerknes R Serum eosinophil cationic protein and interleukin-5 in children with bronchial asthma and acute branchiolitis. Pediatr. Allergy Immunol. 1996; 7: 180-6.
20. Zhao J, Takamura M, Yamaoka A, Odajima Y, Iikura Y. Altered eosinophil levels as a result of viral infection in asthma exacerbation in childhood. Pediatr. Allergy Immunol. 2002; 13: 47-50.
21. Kim CK, Kim SW, Park CS, Kim BI, Kang H, Koh YY. Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis. J. Allergy Clin. Immunol. 2003; 112: 64-71.
22. Schwarze J, Hamelmann E, Bradley KL, Takeda K, Gelfand EW. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J. Clin. Invest. 1997; 100: 226-33.
23. Schwarze J, Cieslewicz G, Hamelmann E et al. IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection. J. Immunol. 1999; 162: 2997-3004.
24. Schwarze J, Cieslewicz G, Joetham A et al. Critical roles for interleukin-4 and interleukin-5 during respiratory syncytial virus infection in the development of airway hyperresponsiveness after airway sensitization. Am. J. Respir. Crit. Care Med. 2000; 162: 380-6.
25. Kimpen JL, Garofalo R, Welliver RC, Ogra PL. Activation of human eosinophils in vitro by respiratory syncytial virus. Pediatr. Res. 1992; 32: 160-4.
26. Kimpen JL, Garofalo R, Welliver RC, Fujihara K, Ogra PL. An ultra structural study of the interaction of human eosinophils with respiratory syncytial virus. Pediatr. Allergy Immunol. 1996; 7: 48-53.
27. Olszewska-Pazdrak B, Casola A, Saita T et al. Cell-specific expression of RANTES, MCP-1, and MIP-1α by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J. Virol. 1998; 72: 4756-64.
28. Tachibana A, Kimura H, Kata M, Naka Y, Kozawa K, Morikawa A. Respiratory syncytial virus enhances expression of CD11b molecules and the generation of superoxide anion by human eosinophils primed with platelet-activating factor. Intervirolagy 2002; 45: 43-51.
29. Nakamura M, Honda Z, Izumi T et al. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J. Biol. Chem. 1991; 266: 20 400-5.
30. Lub M, Kooyk YV, Figgor CG. Ins and outs of LFA-1. Immunol. Today 1995; 16: 479-83.
31. Kato M, Abraham RT, Okada S, Kita H. Ligation of the beta-2 integrin triggers activation and degranulation of human eosinaphils. Am. J. Respir. Cell Mol. Biol. 1998; 18: 675-86.
32. Kurt-Jones EA, Popova L, Kwinn L et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 2000; 5: 398-401.
33. Tripp RA, Janes LP, Haynes LM, Zheng H, Murphy PM, Anderson U. CX3C chemakine mimicry by respiratory syncytial virus G glycoprotein. Nat. Immunol. 2001; 8: 732-8.
34. Stark JM, Godding V, Sedgwick JB, Busse WW. Respiratory syncytial virus infection enhances neutrophil and eosinophil adhesion to cultured respiratory epithelial cells. J. Immunol. 1996; 156: 4774-82.
35. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinaphil and basophil recruitment. J. Allergy Clin. Immunol. 1994; 94: 427-38.
36. Olszewska-Pazdrak B, Pazdrak K, Ogra PL, Garafalo RP. Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinaphil degranulation by a CD18-mediated mechanism. J. Immunol. 1998; 160: 4889-95.
37. Soukup JM, Becker S. Role of monocytes and eosinophils in human respiratory syncytial virus infection in vitro. Clin. Immunol. 2003; 107: 178-85.
38. Domachowske JB, Dyer KD, Banville CA, Rosenberg HF. Recombinant human eosinophil-derived neurotoxin/ RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J. Infect. Dis. 1998; 177: 1458-64.
39. Domachowshe JB, Dyer KD, Adams AG, Leto TL, Rosenberg HF. Eosinophil cationic protein/Rnase 3 is another Rnase A-family ribonuclease with direct antiviral activity. Nucleic Acids Res. 1998; 26: 3358-63.